Skip to content

Clinical trials

Phase 2/3 COVID-19 trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 2/3 Country / region: Germany Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20208
20213
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated6
Completed5
Withdrawn2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Invivyd, Inc.2
Abivax S.A.1
AstraZeneca1
BioNTech SE1
CureVac1
Hellenic Institute for the Study of Sepsis1
Immunic AG1
Karolinska Institutet1
Merck Sharp & Dohme LLC1
NEAT ID Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1914
Coronavirus Infections2
Communicable Diseases, Emerging1
Cytokine Release Syndrome1
Lymphoma, Follicular1
Post-Acute COVID-19 Syndrome1
Respiratory Distress Syndrome1
Severe Acute Respiratory Syndrome1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.